Open access
Open access
Powered by Google Translator Translator

All Posts

WHO recommends antibody treatment for COVID patients at high risk of hospital admission.

24 Sep, 2021 | 10:11h | UTC

WHO recommends antibody treatment for COVID patients at high risk of hospital admission – British Medical Journal

Original article and infographic: A living WHO guideline on drugs for covid-19 – The BMJ

 


Expert panel recommends against use of race in assessment of kidney function.

24 Sep, 2021 | 09:01h | UTC

Expert panel recommends against use of race in assessment of kidney function – STAT

Original Guidance: A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease – American Journal of Kidney Diseases

 

Commentary on Twitter

 


COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.

24 Sep, 2021 | 10:02h | UTC

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants – Cell

 

Commentary on Twitter

https://twitter.com/Sri_Baqri/status/1438865999281983490

 


Review | Interplay between endocrinology, metabolism, and COVID-19 infection.

24 Sep, 2021 | 10:00h | UTC

Interplay between endocrinology, metabolism, and COVID-19 infection – Clinical Medicine Journal

 


Landmark articles suggest eliminating race in the estimation of kidney function.

24 Sep, 2021 | 09:03h | UTC

Editorial: Time to Eliminate Health Care Disparities in the Estimation of Kidney Function – New England Journal of Medicine

Study 1: New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race – New England Journal of Medicine

Study 2: Race, Genetic Ancestry, and Estimating Kidney Function in CKD – New England Journal of Medicine

Commentaries:

NIH-supported study suggests alternative to race-based kidney function calculations – NIH News Releases

Remove Race From Equation Used to Assess Kidney Function, Researchers Say – AJMC

Researchers identify potential approach to eliminate race from equations to estimate kidney function – News Medical

 

Commentary on Twitter

 


RCT confirms antibiotics are not needed for most children with uncomplicated lower respiratory tract infection if pneumonia is not suspected clinically.

24 Sep, 2021 | 09:00h | UTC

Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial – The Lancet

 

Commentary on Twitter

 


Cohort Study: Insulin resistance linked to increased risk of major depressive disorder.

24 Sep, 2021 | 08:59h | UTC

Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study – The American Journal of Psychiatry

Commentaries:

Insulin Levels, BMI in Youth May Be Linked to Psychosis, Depression Risk in Adulthood – Psychiatric News

Insulin Resistance Linked to Major Depressive Disorder, Dutch Study Finds – Psychiatric News Alert

Insulin resistance doubles risk of major depressive disorder – Stanford Medicine

 


Clinical practice guideline on immune checkpoint inhibitor-related adverse events.

24 Sep, 2021 | 08:55h | UTC

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events – Journal for ImunoTherapy of Cancer

Related:

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities (several resources on the subject)

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment (several resources on the subject)

 


WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18 – In many countries, ciprofloxacin resistance was exceedingly high, and decreased susceptibility or resistance to ceftriaxone and cefixime continued to emerge.

24 Sep, 2021 | 08:53h | UTC

WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study – The Lancet Microbe

 


Large, multinational cohort suggests ondansetron use in pregnancy does not increase the risk for adverse fetal outcomes.

24 Sep, 2021 | 08:57h | UTC

Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort – JAMA Network Open

Editorial: Providing Data to Empower Pregnant Patients to Make Evidence-Based Choices

Related: Cohort Study: Maternal Ondansetron Use and Risk of Cardiac Malformations and Oral Clefts in Offspring

 

Commentary on Twitter

 


European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients.

24 Sep, 2021 | 08:54h | UTC

European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus- UEG Journal

 


[Preprint] Third dose of Sinopharm inactivated SARS-CoV-2 vaccine induces robust B and T cell responses.

23 Sep, 2021 | 10:18h | UTC

Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine – medRxiv

Commentaries:

Three doses of inactivated BBIBP-CorV SARS-CoV-2 vaccine induce robust B and T cell responses – News Medical

Sinopharm’s COVID booster reverses antibody decline, enhances cell-based responses – study – Reuters

 


Review: Focused management of patients with severe acute brain injury and ARDS.

24 Sep, 2021 | 08:52h | UTC

Focused Management of Patients with Severe Acute Brain Injury and ARDS – CHEST

 


Cochrane Special Collection | De-implementation of low-value health care: resource prioritization in the COVID-19 pandemic era.

23 Sep, 2021 | 10:13h | UTC

De-implementation of low-value health care: resource prioritization in the COVID-19 pandemic era – Cochrane Library

Editorial: Making wise choices about low‐value health care in the COVID‐19 pandemic – Cochrane Library

Commentary: Choosing health care wisely when resources are scarce – Evidently Cochrane

 

Commentaries on Twitter

 


Randomized phase 1/2 trial: Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in children and adolescents aged 3–17 years.

23 Sep, 2021 | 10:16h | UTC

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial – The Lancet Infectious Diseases

Related: Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years.

 


‘Not a zero-sum game’: Sharing vaccines is in countries’ best interests.

23 Sep, 2021 | 10:09h | UTC

‘Not a zero-sum game’: Sharing vaccines is in countries’ best interests – YaleNews

Original article: National interest may require distributing COVID-19 vaccines to other countries – Scientific Reports

 

Commentary on Twitter

 


Systematic review: Clinical characteristics of multisystem inflammatory syndrome in adults.

23 Sep, 2021 | 10:12h | UTC

Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review – JAMA Network Open

 

Commentary on Twitter

 


WHO releases new compendium of innovative health technologies for COVID-19 and other priority diseases.

23 Sep, 2021 | 10:03h | UTC

WHO releases new compendium of innovative health technologies for COVID-19 and other priority diseases – World Health Organization

Compendium: WHO compendium of innovative health technologies for low-resource settings 2021. COVID-19 and other health priorities – World Health Organization

 


The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

23 Sep, 2021 | 10:08h | UTC

The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable – Nature Medicine

 

Commentary on Twitter

 


AHA Scientific Statement: Sleep‐disordered breathing and cardiovascular disease in children and adolescents.

23 Sep, 2021 | 10:02h | UTC

Sleep‐Disordered Breathing and Cardiovascular Disease in Children and Adolescents: A Scientific Statement From the American Heart Association – Journal of the American Heart Association

News release: Obstructive sleep apnea is common in kids and may impact blood pressure, heart health – American Heart Association

 


ERS clinical practice guidelines on treatment of sarcoidosis.

23 Sep, 2021 | 10:00h | UTC

ERS clinical practice guidelines on treatment of sarcoidosis – European Respiratory Journal

 


New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution.

23 Sep, 2021 | 10:05h | UTC

News release: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution – World Health Organization

Original Guideline: WHO global air quality guidelines: particulate matter (‎PM2.5 and PM10)‎, ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide

Executive Summary: WHO global air quality guidelines: particulate matter (‎PM2.5 and PM10)‎, ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide

Commentaries:

Millions of deaths could be avoided under new air quality guidelines, WHO says – CNN

Combatting an invisible killer: New WHO air pollution guidelines recommend sharply lower limits – The Conversation

WHO slashes guideline limits on air pollution from fossil fuels – The Guardian

 


Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system—part V, knee.

23 Sep, 2021 | 09:59h | UTC

Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)—part V, knee – European Radiology

See other articles in the series: Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system.

 


Consensus Document: Evaluation and management of cancer patients presenting with acute cardiovascular disease—Part 1: acute coronary syndromes and acute pericardial diseases.

23 Sep, 2021 | 10:01h | UTC

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology—Part 1: acute coronary syndromes and acute pericardial diseases – European Heart Journal. Acute Cardiovascular Care

Related:

Brazilian Cardio-oncology Guideline – 2020

AHA Scientific Statement: Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology.

ESMO Consensus Recommendations: Management of Cardiac Disease in Cancer Patients Throughout Oncological Treatment

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement from the American Heart Association – Circulation

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations – Revista Espanola de Cardiologia (free)

AHA Statement: Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors

 

Commentary on Twitter

 


Expert Analysis | Colchicine in acute coronary syndrome: when to commence?

23 Sep, 2021 | 09:56h | UTC

Colchicine in Acute Coronary Syndrome: When to Commence? – American College of Cardiology

Related:

M-A: Colchicine in patients with coronary artery disease – “colchicine reduces the risk of myocardial infarction and stroke, but has a higher rate of gastrointestinal upset with no influence on all‐cause mortality”.

Review: Colchicine and the heart.

M-A: Colchicine administration for percutaneous coronary intervention

M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease

Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease

#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome

#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

#AHA19 – [Abstract Only] Practice Changing? – Randomized Trial: Low-Dose Colchicine Improves Outcomes after Myocardial Infarction

Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.